検索結果
Takeuchi, M. ,
Suda, K. ,
Hamamoto, Y. ,
Kato, M. ,
Mayanagi, S. ,
Yoshida, K. ,
Fukuda, K. ,
Nakamura, R. ,
Wada, N. ,
Kawakubo, H. ,
Takeuchi, H. ,
Yahagi, N. &
Kitagawa, Y. ,
2018 9月 ,
In: Gastrointestinal Endoscopy. 88 ,
3 ,
p. 456-465 10 p. 研究成果: Article › 査読
Esophagectomy
100%
Esophageal Neoplasms
87%
Safety
49%
Disease-Free Survival
26%
Survival
15%
Shimozaki, K. ,
Hirata, K. ,
Horie, S. ,
Chida, A. ,
Tsugaru, K. ,
Hayashi, Y. ,
Kawasaki, K. ,
Miyanaga, R. ,
Hayashi, H. ,
Mizuno, R. ,
Funakoshi, T. ,
Hosoe, N. ,
Hamamoto, Y. &
Kanai, T. ,
2021 3月 ,
In: Diagnostics. 11 ,
3 , 543.
研究成果: Article › 査読
Capsule Endoscopy
100%
Enterocolitis
78%
Observational Studies
57%
Prospective Studies
46%
Small Intestine
14%
Okada, M. ,
Kato, K. ,
Cho, B. C. ,
Takahashi, M. ,
Lin, C. Y. ,
Chin, K. ,
Kadowaki, S. ,
Ahn, M. J. ,
Hamamoto, Y. ,
Doki, Y. ,
Yen, C. C. ,
Kubota, Y. ,
Kim, S. B. ,
Hsu, C. H. ,
Holtved, E. ,
Xynos, I. ,
Matsumura, Y. ,
Takazawa, A. &
Kitagawa, Y. ,
2022 8月 1 ,
In: Clinical Cancer Research. 28 ,
15 ,
p. 3277-3286 10 p. 研究成果: Article › 査読
Nivolumab
100%
Esophageal Squamous Cell Carcinoma
87%
Survival
40%
Drug Therapy
37%
Docetaxel
10%
Hamamoto, Y. ,
Sakakibara, N. ,
Nagashima, F. ,
Kitagawa, Y. &
Higashi, T. ,
2018 4月 1 ,
In: Esophagus. 15 ,
2 ,
p. 109-114 6 p. 研究成果: Article › 査読
Chemoradiotherapy
100%
Esophageal Neoplasms
95%
Databases
56%
Costs and Cost Analysis
25%
Radiotherapy
21%
Hand-Foot Syndrome
100%
Foot
58%
Hand
52%
Drug Therapy
41%
Skin
38%
gemcitabine
100%
Pancreatic Neoplasms
84%
Survival
24%
Confidence Intervals
10%
Taiwan
8%
Hamamoto, Y. ,
Endo, T. ,
Nosho, K. ,
Arimura, Y. ,
Sato, M. &
Imai, K. ,
2004 1月 ,
In: Journal of gastroenterology. 39 ,
1 ,
p. 14-20 7 p. 研究成果: Article › 査読
Narrow Band Imaging
100%
Barrett Esophagus
83%
Endoscopy
61%
Esophagogastric Junction
14%
Capillaries
11%
Hirata, K. ,
Hamamoto, Y. ,
Ando, M. ,
Imamura, C. K. ,
Yoshimura, K. ,
Yamazaki, K. ,
Hironaka, S. &
Muro, K. ,
2020 6月 12 ,
In: BMC cancer. 20 ,
1 , 548.
研究成果: Article › 査読
ramucirumab
100%
130-nm albumin-bound paclitaxel
95%
Paclitaxel
62%
Stomach Neoplasms
53%
Japan
50%
Shimozaki, K. ,
Hirata, K. ,
Sato, T. ,
Nakamura, M. ,
Kato, K. ,
Hirano, H. ,
Kumekawa, Y. ,
Hino, K. ,
Kawakami, K. ,
Kito, Y. ,
Matsumoto, T. ,
Kawakami, T. ,
Komoda, M. ,
Nagashima, K. ,
Sato, Y. ,
Yamazaki, K. ,
Hironaka, S. ,
Takaishi, H. ,
Hamamoto, Y. &
Muro, K. ,
2022 12月 ,
In: Clinical Colorectal Cancer. 21 ,
4 ,
p. 339-346 8 p. 研究成果: Article › 査読
Vascular Endothelial Growth Factor A
100%
Colorectal Neoplasms
92%
Registries
91%
Safety
67%
Survival
27%